AI assistant
LEMAITRE VASCULAR INC — Director's Dealing 2019
Jun 10, 2019
31708_dirs_2019-06-10_7a180342-b78e-4c85-942a-20af0dd37da2.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: LEMAITRE VASCULAR INC (LMAT)
CIK: 0001158895
Period of Report: 2019-06-06
Reporting Person: Kamke Trent G (Senior V. P., Operations)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2019-06-06 | Dividend Equivalent Rights | $ | A | 4 | Acquired | Common Stock (4) | Direct | |
| 2019-06-06 | Dividend Equivalent Rights | $ | A | 2 | Acquired | Common Stock (2) | Direct | |
| 2019-06-06 | Dividend Equivalent Rights | $ | A | 4 | Acquired | Common Stock (4) | Direct |
Footnotes
F1: These dividend equivalent rights accrued on a restricted stock unit award granted on 7/25/2016 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
F2: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/22/2017 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
F3: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/19/2018 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.